You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

induction regimen

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Germ Cell Tumor Trial in United States (Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).)

Completed
  • CNS Germ Cell Tumor
  • Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).
  • Phoenix, Arizona
  • +4 more
Jan 5, 2021

Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

Active, not recruiting
  • Ganglioneuroblastoma
  • High Risk Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +14 more
  • Los Angeles, California
  • +9 more
Sep 1, 2022

Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

High-risk Neuroblastoma Trial in Charlotte (Naxitamab, Ceritinib)

Not yet recruiting
  • High-risk Neuroblastoma
  • Charlotte, North Carolina
    Levine Children's Hospital
Aug 4, 2022

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Split-course hypo-CCRT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Aug 26, 2023

Pregnant Patients With Obesity Trial in Columbus (High-dose oxytocin, Low-dose oxytocin)

Active, not recruiting
  • Pregnant Patients With Obesity
  • High-dose oxytocin
  • Low-dose oxytocin
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center OB/GYN Maternal
Sep 23, 2022

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Pregnancy, Labor, Induced Trial in Dallas (Vaginal Misoprostol, Oral Misoprostol)

Recruiting
  • Pregnancy
  • Labor, Induced
  • Vaginal Misoprostol
  • Oral Misoprostol
  • Dallas, Texas
    Parkland Health and Hospital Systems
Sep 27, 2022

Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Ann Arbor, Michigan
  • +3 more
Jan 19, 2023

Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

Recruiting
  • Acute Lymphoid Leukemia
  • +3 more
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Jul 24, 2023

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
  • (no location specified)
Nov 11, 2023

MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

Not yet recruiting
  • Multiple Myeloma
  • Minimal Residual Disease
    • (no location specified)
    Nov 1, 2023

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Liver Transplantation Trial in Stockholm (TCD601, Cyclophosphamide, TAC)

    Recruiting
    • Liver Transplantation
    • TCD601
    • +4 more
    • Stockholm, Huddinge, Sweden
      Karolinska University Hospital
    Aug 25, 2023

    Opioid Use Disorder Trial (buprenorphine/naloxone)

    Not yet recruiting
    • Opioid Use Disorder
    • (no location specified)
    Jul 10, 2023

    Stem Cells Mobilization, colLection and Engraftment in Newly

    Recruiting
    • Multiple Myeloma
    • +3 more
    • Rome, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Apr 28, 2023

    Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

    Active, not recruiting
    • Chronic Lymphoid Leukemia
    • Dresden, Germany
    • +16 more
    Nov 8, 2022

    Induction Chemo, Acute T-Lymphocytic Leukemia, T-cell Lymphoblastic Lymphoma Leukemia Trial in Suzhou (Decitabine combined with

    Recruiting
    • Induction Chemotherapy
    • +3 more
    • Decitabine combined with HAAG Regimen
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jun 22, 2020

    HLH Trial in Beijing (Teniposide)

    Recruiting
    • HLH
    • Beijing, China
      Zhao Wang
    Sep 15, 2023

    Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

    Recruiting
    • Acute Myeloid Leukemia
    • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
    • "3+7"
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Sep 29, 2023

    Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • cladribine + homoharringtonine + cytarabine
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University School of Med
    Jun 13, 2023

    Opioid Dependence Fentanyl Trial in Harrisburg (Buprenorphine/naloxone)

    Recruiting
    • Opioid Dependence Fentanyl
    • Harrisburg, Pennsylvania
      The Pennsylvania Psychiatric Institute
    Dec 1, 2022

    HLH Trial in Beijing (Thiotepa)

    Recruiting
    • HLH
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    May 10, 2023

    Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

    Recruiting
    • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 13, 2022